IncFact
Company Profiles: Revenue, Growth, Competition

ADVAXIS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Advaxis

Access the complete profile.

Advaxis Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes541711 Research & Development in Biotechnology
Address305 College Road East
Princeton, NJ 08540

advaxis.com


Advaxis's annual revenues are $10-$50 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.


Advaxis's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Advaxis is a publicly traded company on NMS using the ticker symbol ADXSW. Detailed information on company financials and operating reports can be found here: NMS: ADXSW



Advaxis Annual Revenue and Growth Rate

Advaxis Revenue Est.
($ Million)
Growth Rate (%)# Employees
2019 Details in Premium Report
2018
2017
2016
2015
2014


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Advaxis's revenues are gauged from an analysis of company filings.



Investor Activity

Advaxis has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
December 13, 2012 1 0%$10 MM
Complete list of funding rounds and total amounts in the Company Report




Trademark Applications

Trademark applications show the products and services that Advaxis is developing and marketing. Advaxis doesn't have any recent trademark applications, indicating Advaxis is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ADVAXIS
Pharmaceuticals, pharmaceutical compositions, and pharmaceutical preparations, all for the treatment of cancer and for immunotherapy
12/09/2016
ADXS11-001
Pharmaceutical preparations for the treatment of cancer
12/08/2016
MINE
BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNOLOGICAL CONDITIONS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF TUMORS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNE SYSTEM CONDITIONS; MEDICINAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES AND FOR USE IN ONCOLOGY; BIOPHARMACEUTICAL PREPARATIONS FOR PERSONALIZED CANCER IMMUNOTHERAPIES AND IMMUNO-ONCOLOGY THERAPIES
08/02/2016

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Advaxis grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Advaxis is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Advaxis's Largest Competitors

A competitive analysis shows these companies are in the same general field as Advaxis, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
OMNICARECincinnati, OH100 
LEIDOSReston, VA91 
INC RESEARCHMorrisville, NC62 
SCIENCE APPLICATIONS INTERNATIONALReston, VA61 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM49 
CEPHALONFrazer, PA44 
COVANCEPrinceton, NJ35 
SYNEOS HEALTHRaleigh, NC29 
INCYTEWilmington, DE29 




Nearby Competitors

These companies are similar in business line and location to Advaxis. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
COVANCEPrinceton, NJ100 
AMICUS THERAPEUTICS USCranbury, NJ4 
ADVAXISPrinceton, NJ3 
TAIHO ONCOLOGYPrinceton, NJ2 
HOVIONEEast Windsor, NJ1 
PRINCTON SCIENCE INC. SCITECPrinceton, NJ1 




Future Competition: Advaxis's Fastest Growing Competitors

These companies are in the same general field as Advaxis and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Advaxis Competitors